CYT - Cyteir Therapeutics, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 3.02

Open

$ 3.06

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.01 - $ 3.06

52 Week Range

$ 1.48 - $ 3.19

Volume

1,006,884

Average Volume

Market Cap

108.81M

Beta (5Y Monthly)

$ 1.53

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2023	09-30-2023	10-Q
2	08-07-2023	06-30-2023	10-Q
3	05-10-2023	03-31-2023	10-Q
4	03-23-2023	12-31-2022	10-K
5	11-07-2022	09-30-2022	10-Q
6	08-08-2022	06-30-2022	10-Q
7	05-05-2022	03-31-2022	10-Q
8	03-16-2022	12-31-2021	10-K
9	11-12-2021	09-30-2021	10-Q
10	08-09-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

The Official Delisting Of Cyteir's Common ...
03/07/2024 21:53:55

Cyteir Announces On Or About March 18, 202...
03/07/2024 21:53:37

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT) today announced that it has formally notified The Nasdaq Stock Market...

B of A Securities Downgrades Cyteir Therap...
01/05/2024 16:14:19

B of A Securities analyst Tazeen Ahmad downgrades Cyteir Therapeutics (NASDAQ:CYT) from Neutral to Underperform and announce...

Cyteir Therapeutics Presented Ongoing Resu...
10/12/2023 11:36:23

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT) today presented ongoing results from a dose expansion cohort in its P...

nasdaq-jumps-200-points-baudax-bio-shares-spike-higher

Nasdaq Jumps 200 Points; Baudax Bio Shares...
06/30/2023 18:34:18

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded u...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
06/30/2023 17:37:38

why-cineverse-shares-are-trading-lower-by-18-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Cineverse Shares Are Trading Lower By ...
06/30/2023 16:34:37

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artifici...

Crude Oil Rises Over 1%; Fed's Preferred I...
06/30/2023 16:01:22

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up ...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
06/30/2023 13:12:33

Cyteir Therapeutics Announces Discontinuat...
06/30/2023 12:07:58

Cyteir Therapeutics, Inc. ("Cyteir" or the "Company") (NASDAQ:CYT) today announced that it is discontinuing all...

Wedbush Reiterates Outperform on Cyteir Th...
05/12/2023 13:52:09

Wedbush analyst Robert Driscoll reiterates Cyteir Therapeutics (NASDAQ:CYT) with a Outperform and maintains $3 price target.

Cyteir Therapeutics Q4 EPS $(0.25) Beats $...
03/23/2023 20:20:24

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(...

Cyteir Therapeutics Promotes David Gaiero ...
02/06/2023 13:16:53

David was previously Vice President of Finance at Cyteir.

Benzinga's Top Ratings Upgrades, Downgrade...
02/03/2023 15:00:42

Morgan Stanley Downgrades Cyteir Therapeut...
02/03/2023 11:20:44

Morgan Stanley analyst Jeffrey Hung downgrades Cyteir Therapeutics (NASDAQ:CYT) from Equal-Weight to Underweight and lowers ...

Benzinga's Top Ratings Upgrades, Downgrade...
01/30/2023 15:00:50

B of A Securities Downgrades Cyteir Therap...
01/30/2023 12:17:59

B of A Securities analyst Tazeen Ahmad downgrades Cyteir Therapeutics (NASDAQ:CYT) from Buy to Neutral and lowers the price ...

Benzinga's Top Ratings Upgrades, Downgrade...
01/20/2023 15:00:42

JP Morgan Downgrades Cyteir Therapeutics t...
01/20/2023 09:54:40

JP Morgan analyst Anupam Rama downgrades Cyteir Therapeutics (NASDAQ:CYT) from Overweight to Neutral.

Cyteir Therapeutics Announces Prioritizati...
01/19/2023 21:31:41